首页> 外文学位 >Synthesis and evaluation of novel amphiphilic macromolecules as drug carriers and therapeutics.
【24h】

Synthesis and evaluation of novel amphiphilic macromolecules as drug carriers and therapeutics.

机译:新型两亲大分子作为药物载体和治疗剂的合成与评价。

获取原文
获取原文并翻译 | 示例

摘要

Novel amphiphilic star-like macromolecules (ASM) and amphiphilic scorpion-like macromolecules (AScM) with double-chained and single-chained tails were synthesized and characterized. All macromolecules are composed of mucic acid-based hydrophobic "heads" and poly(ethylene glycol)-based hydrophilic "tails". Two different ASMs (M12P5 and M12P2x2) and two different AScMs (NC12P5 and NC12P2x2) were investigated to explore how branched PEG chains influence particle size, water-solubility, drug loading capacity, drug release rate and micelle stability. A hydrophobic, anti-inflammatory drug (indomethacin) was used to evaluate the encapsulation ability and release rate from the macromolecules. The double-chained macromolecules reduced the micellar sizes (10 nm for AScM, 22 nm for ASM) compared to single-chained macromolecules (18 nm for AScM, 48 nm for ASM). Through oil/water emulsion methods, drug-loading efficiency of ASM reached nearly 50%, higher than the self-assembled micelle AScMs, which display a drug-loading efficiency 30%. Indomethacin-loaded ASM released 52% of free drug within 50 hours, compared with 78% for AScM. Dynamic light scattering experiments showed that ASM minimized protein interactions. Double-chained macromolecules perform as well or better than single-chained ones as drug delivery systems.;Several AScMs, which bear carboxylate groups on hydrophilic and hydrophobic domains, were also prepared. These macromolecules formed extremely stable micelles in aqueous solution with an average size of 20-35 nm and critical micelle concentration (CMC) as low as 10-7 M. Zeta potential values and micellar sizes in neutral buffer solutions correlated well with the carboxylate location and numbers. All macromolecules are capable of inhibiting unregulated uptake of highly-oxidized low density lipoproteins (LDL) by macrophages. This inhibition is caused by the interaction of scavenger receptors with negatively charged macromolecules, and closely responds to the number and location of negative charges. The AScM with one carboxylate at the hydrophobic domain and one carboxylate at hydrophilic domain exhibited the best LDL inhibition. To further enhance the treatment, a ligand GW 3965 was loaded into the AScM micelle.
机译:合成并表征了新型的两亲性星状大分子(ASM)和具有双链和单链尾巴的两亲性蝎子状大分子(AScM)。所有大分子均由基于粘酸的疏水“头”和基于聚乙二醇的亲水“尾”组成。研究了两种不同的ASM(M12P5和M12P2x2)和两种不同的AScM(NC12P5和NC12P2x2),以探索PEG支链如何影响粒径,水溶性,载药量,药物释放速率和胶束稳定性。使用疏水性抗炎药(吲哚美辛)评估大分子的包封能力和释放速率。与单链大分子(AScM为18 nm,ASM为48 nm)相比,双链大分子减小了胶束尺寸(AScM为10 nm,ASM为22 nm)。通过油/水乳化法,ASM的载药效率达到近50%,高于自组装的胶束AScMs的载药效率30%。负载吲哚美辛的ASM在50小时内释放了52%的游离药物,而AScM则为78%。动态光散射实验表明,ASM使蛋白质相互作用最小化。双链大分子的性能与药物输送系统相同或优于单链大分子。还制备了几个在亲水和疏水域上带有羧基的AScM。这些大分子在水溶液中形成极其稳定的胶束,平均尺寸为20-35 nm,临界胶束浓度(CMC)低至10-7M。中性缓冲溶液中的Zeta电位值和胶束尺寸与羧酸盐位置和数字。所有大分子都能够抑制巨噬细胞对高氧化性低密度脂蛋白(LDL)的无规律摄取。这种抑制作用是由清除剂受体与带负电荷的大分子的相互作用引起的,并且与负电荷的数量和位置密切相关。在疏水域具有一个羧酸盐和在亲水域具有一个羧酸盐的AScM表现出最好的LDL抑制。为了进一步增强治疗效果,将配体GW 3965装入AScM胶束中。

著录项

  • 作者

    Wang, Jinzhong.;

  • 作者单位

    Rutgers The State University of New Jersey - New Brunswick.;

  • 授予单位 Rutgers The State University of New Jersey - New Brunswick.;
  • 学科 Chemistry Organic.;Chemistry Polymer.
  • 学位 Ph.D.
  • 年度 2007
  • 页码 136 p.
  • 总页数 136
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号